Contrary to the favorable anti-inflammatory, insulin-sensitizing, and cardioprotective effects of adiponectin in healthy subjects, varying results have been obtained for the association between adiponectin and adverse outcomes in CKD. This evidence concerns the gene INS and chronic kidney disease.